CGAM Hero

BRINGING

YOUR

SCIENCE

TO LIFE

Customer Journey 1
PlayPlay
New CEO Pascal Villemagne
previous arrow
next arrow

LATEST NEWS

  • CARBOGEN AMCIS opens new state-of-the-art facility dedicated to sterile liquid drug product manufacturing in France

    CARBOGEN AMCIS opens new state-of-the-art facility dedicated to sterile liquid drug product manufacturing in France

    CARBOGEN AMCIS opens new state-of-the-art facility dedicated to sterile liquid drug product manufacturing in France

    Bubendorf, Switzerland (3 February 2023) – Switzerland-based CARBOGEN AMCIS, a pharmaceutical process development and Active Pharmaceutical Ingredient (API) manufacturing company, has opened a state-of-the-art facility in Saint-Beauzire, France.

    The new site is dedicated to the custom development and production of sterile injectable drug products. Built on newly acquired land located 7km from an existing CARBOGEN AMCIS site in Riom, the new...

  • CARBOGEN AMCIS announces successful Swissmedic inspection at Vionnaz, Switzerland

    CARBOGEN AMCIS announces successful Swissmedic inspection at Vionnaz, Switzerland

    CARBOGEN AMCIS announces successful Swissmedic inspection at Vionnaz, Switzerland

    Bubendorf, Switzerland (Septembre 29, 2022) – Switzerland-based CARBOGEN AMCIS AG, a pharmaceutical process development and Active Pharmaceutical Ingredient (API) manufacturing company, announced that its site in Vionnaz, Switzerland has successfully completed a Swissmedic inspection performed by Regional Medicines Inspectorate of Western Switzerland (ISOPTh).

    The two-day inspection took place from September 20th to 21th, 2022 and was undertaken by an inspector of Regional Medicines Inspectorate of Western Switzerland...

  • CARBOGEN AMCIS appointed new Vice President of Business Development, Sales & Marketing

    CARBOGEN AMCIS appointed new Vice President of Business Development, Sales & Marketing

    CARBOGEN AMCIS appointed new Vice President of Business Development, Sales & Marketing

    BUBENDORF, Switzerland (July 21, 2022) — Switzerland-based CARBOGEN AMCIS, a pharmaceutical process development and Active Pharmaceutical Ingredient (API) manufacturing company, announced today the appointment of François Baduel as Vice President of Business Development, Sales & Marketing.

    In his new role, François Baduel will lead the company’s overall sales and marketing operations. He will report directly to Pascal Villemagne, Chief Executive Officer,...

  • Pascal Villemagne appointed new CARBOGEN AMCIS Chief Executive Officer (CEO)

    Pascal Villemagne appointed new CARBOGEN AMCIS Chief Executive Officer (CEO)

    Pascal Villemagne appointed new CARBOGEN AMCIS Chief Executive Officer (CEO)

    BUBENDORF, Switzerland (March 31, 2022) — Switzerland-based CARBOGEN AMCIS, a pharmaceutical process development and Active Pharmaceutical Ingredient (API) manufacturing company, announces that Pascal Villemagne has been named Chief Executive Officer, effective first of April

    In his new role, Pascal Villemagne will be leading CARBOGEN AMCIS and its nine sites around the world. He will report to Arpit Vyas, Global Managing Director of Dishman Carbogen Amcis Ltd., CARBOGEN AMCIS’ parent company. Villemagne, who has served as Vice President of Sales...

  • Dishman Carbogen Amcis Ltd announces successful results from the partnership with Boston University School of Medicine on Clinical Research Study that reveals positive response in vitamin D deficiency/insufficiency in patients with COVID-19

    Dishman Carbogen Amcis Ltd announces successful results from the partnership with Boston University School of Medicine on Clinical Research Study that reveals positive response in vitamin D deficiency/insufficiency in patients with COVID-19

    Dishman Carbogen Amcis Ltd announces successful results from the partnership with Boston University School of Medicine on Clinical Research Study that reveals positive response in vitamin D deficiency/insufficiency in patients with COVID-19

    Ahmedabad, India (December 9th, 2021) — Dishman Carbogen Amcis Limited, a global outsourcing partner for the pharmaceutical industry, welcomes the results of a new Clinical Research Study which shows that oral 25-Hydroxyvitamin D3 (Calcifediol) was able to correct vitamin D deficiency/insufficiency in patients with COVID-19 and that it resulted in improved immune function by increasing blood lymphocyte...

  • NH TherAguix announces the release of a new clinical batch for its drug AGuIX, manufactured by CARBOGEN AMCIS

    NH TherAguix announces the release of a new clinical batch for its drug AGuIX, manufactured by CARBOGEN AMCIS

    NH TherAguix announces the release of a new clinical batch for its drug AGuIX, manufactured by CARBOGEN AMCIS

    MEYLAN, France, BUBENDORF, Switzerland, (November 3rd, 2021) - NH TherAguix, a clinical stage company developing innovative nanomedicine for the treatment of cancer, and CARBOGEN AMCIS, a pharmaceutical process development and Active Pharmaceutical Ingredient (API) and Drug Products manufacturing company, announced today the release of a new batch of AGuIX Drug Product for clinical trials.

    CARBOGEN AMCIS just released the fifth batch of AGuIX Drug Product since inception of the company. The release of this 3.7 kg batch...

  • CARBOGEN AMCIS announces successful FDA inspection of its facility in Aarau, Switzerland

    CARBOGEN AMCIS announces successful FDA inspection of its facility in Aarau, Switzerland

    CARBOGEN AMCIS announces successful FDA inspection of its facility in Aarau, Switzerland

    BUBENDORF, Switzerland (27 October 2021) — Switzerland-based CARBOGEN AMCIS, a pharmaceutical process development and Active Pharmaceutical Ingredient (API) manufacturing company, announces the completion of a U.S. Food and Drug Administration (FDA) inspection at the site in Aarau, Switzerland.

    The pre-approval FDA paper inspection for an intermediate product from a customer was conducted from 17 August - 15 September 2021. By receiving the result in October 2021 the inspection was concluded successfully with no findings, confirming that...

  • CARBOGEN AMCIS announces a co-investment agreement of more than CHF 4 million with a long-standing Europe-based client

    CARBOGEN AMCIS announces a co-investment agreement of more than CHF 4 million with a long-standing Europe-based client

    CARBOGEN AMCIS announces a co-investment agreement of more than CHF 4 million with a long-standing Europe-based client

    BUBENDORF, Switzerland (27 Aug 2021) — Switzerland-based CARBOGEN AMCIS, a pharmaceutical process development and Active Pharmaceutical Ingredient (API) and drug products manufacturing company, announced today the signing of a co-investment agreement with one of its key European customers.

    The agreement provides for additional process capabilities and capacities to facilitate the manufacture of the customer’s commercial product and is following a previous investment of CHF 6 million.

    The recent...

  • CARBOGEN AMCIS acquires new property at Bubendorf site

    CARBOGEN AMCIS acquires new property at Bubendorf site

    CARBOGEN AMCIS acquires new property at Bubendorf site

    • English

      BUBENDORF, Switzerland (24 June, 2021) Switzerland-based CARBOGEN AMCIS, a pharmaceutical process development and Active Pharmaceutical Ingredient (API) and drug products manufacturing company, announced the acquisition of a new property in Bubendorf.  

      CARBOGEN AMCIS confirms the acquisition of further property in Bubendorf (Basel-Landschaft), where the company's headquarters are located. The property in Hauptstrasse 175 has been acquired from the previous owners Marcel und Theres Rutschmann and...

  • CARBOGEN AMCIS announces a co-investment agreement of more than CHF 15 million with a key client to expand Swiss site

    CARBOGEN AMCIS announces a co-investment agreement of more than CHF 15 million with a key client to expand Swiss site

    CARBOGEN AMCIS announces a co-investment agreement of more than CHF 15 million with a key client to expand Swiss site

    BUBENDORF, Switzerland (April 29th, 2021) — Switzerland-based CARBOGEN AMCIS, a pharmaceutical process development and Active Pharmaceutical Ingredient (API) and drug products manufacturing company, announced today a joint funding agreement with a long standing Japan based customer to build  a site extension at the Bubendorf site in Switzerland.  

    The expansion will be created adjacent to an existing manufacturing facility on the Bubendorf Switzerland Site. This important expansion will...

  • Dishman Carbogen Amcis Ltd announces successful results from the partnership with Boston University School of Medicine on study that uncovers treatment for vitamin D deficiency  (2)

    Dishman Carbogen Amcis Ltd announces successful results from the partnership with Boston University School of Medicine on study that uncovers treatment for vitamin D deficiency (2)

    Dishman Carbogen Amcis Ltd announces successful results from the partnership with Boston University School of Medicine on study that uncovers treatment for vitamin D deficiency

    Ahmedabad, India (May 21th, 2021) — India-based Dishman Carbogen Amcis Limited, a global outsourcing partner for the pharmaceutical industry, welcomes the results of a new study that provides critical insights into the treatment of vitamin D deficiency in obesity and in fat malabsorption syndromes. The research was conducted by Boston University School of Medicine and supported in part by a grant from Dishman Carbogen Amcis Ltd’s wholly owned subsidiary CARBOGEN...

  • CARBOGEN AMCIS announces major investments of more than CHF 100 million in Switzerland and France

    CARBOGEN AMCIS announces major investments of more than CHF 100 million in Switzerland and France

    CARBOGEN AMCIS announces major investments of more than CHF 100 million in Switzerland and France

    • English

      BUBENDORF, Switzerland (August 17, 2020) — Switzerland-based CARBOGEN AMCIS, a pharmaceutical process development and Active Pharmaceutical Ingredient (API) and drug products manufacturing company, announced today new expansion plans in Switzerland and France. 

      CARBOGEN AMCIS announces two major expansion projects that will increase manufacturing capacity to better meet the demands of the current market and its customers. The new facilities,...

    UPCOMING EVENTS

    • Zurich Life Science Day 2023

      Zurich Life Science Day 2023

      University of Zurich Irchel Campus, Lichthof, Switzerland

      #3

      Zurich Life Science Day 2023
      The largest life science career day in Switzerland.

       From to 

       

       

       

       

       

      If you are a life scientist, student, or postgraduate, looking for opportunities or just curious and interested in exploring new career paths, then the Zurich Life Science Day is the right event for you! Don't miss your chance to talk to company representatives and to discover the different aspects of the industry through interesting talks and informal meetings. 

      Life Science Zurich Young Scientist Network is a non-profit organization created and run by a group of graduate students & post-docs of the University of Zurich and the ETH Zurich.

    • World ADC London 2023

      World ADC London 2023

      ExCel London Royal Victoria Dock

      31

      World ADC London 2023

       From to 

       

       

       

       

       

      The 13th World ADC London returns in 2023 as Europe’s longest standing and definitive antibody-drug conjugate event - and it’s back bigger and better than before!

      We look forward to meet you!

    • DCAT Week 2023

      DCAT Week 2023

      InterContinental New York Barclay

      Business Meeting Suite #723

      DCAT Week 2023

       From to 

       

       

       

       

       

      DCAT Week is the premier business development event for companies engaged in pharmaceutical development and manufacturing and related industries. Get in contact with us and let's meet at our Business Meeting Suite #723.

    • Bio-Europe Spring 2023 Basel

      Bio-Europe Spring 2023 Basel

      Messe Basel, Switzerland

      #92

      Bio-Europe Spring 2023 Basel

       From to 

       

       

       

       

       

      The business partnering conference BIO-Europe Spring 2023 will take place 20-22 March 2023 in Basel, Switzerland. BIO-Europe Spring will be organised by the EBD Group.

    • Kontakttag Life Science FHNW 2023

      Kontakttag Life Science FHNW 2023

      FHNW Campus Muttenz, Hofackerstrasse 30, Muttenz

      Kontakttag 2023

       From to 

       

       

       

       

       

      The School of Life Sciences FHNW, located in Muttenz near Basel, is part of the largest life sciences location in Europe. At the "Kontakttag 2023", students have the opportunity to learn more about career opportunities at CARBOGEN AMCIS and to get in touch with us. We are looking forward to an inspiring exchange.

    • Bio Korea 2023

      Bio Korea 2023

      Seoul, Korea

      Bio Korea 2023

       From to 

       

       

       

       

       

      Since 2006, BIO KOREA has been holding the International Convention every year for invigorating and growing the global bio-health industry. This year also, we are pleased to announce the 18th BIO KOREA will be held on May 10-12, 2023 at COEX, Seoul. Through various programs of BIO KOREA 2023 including Conferences, Business Partnering, Exhibition, and Invest Fair, exchange the newest bio-health trends and technology as well as get the global expansion business opportunity with various international academics, professionals, and CEOs of the global bio-health field.

    • Biomed 2023

      Biomed 2023

      DavidIntercontinental, Tel Aviv, Israel

      35

      Biomed 2023

       From to 

       

       

       

       

       

      This year’s conference is co-organized by leading Israeli and international healthcare institutions with the objective of exposing participants to thought leaders and experts and allow local and global attendees to mix and exchange knowledge and ideas. 

      As the leading event of Israel’s life sciences industry, Biomed has positioned itself as the main annual meeting place for both Israeli and international players. It presents a unique and exuberating occasion to participate in discussions, panel presentations, product demonstrations and networking opportunities, all paving the way for new business collaborations.

      Our previous successful conferences hosted over 6,000 industry executives, scientists, doctors, engineers, and investors, including approximately 1,000 international participants from over 45 countries and more than 4,500 one-on-one meetings.

      We look forward to meet you at booth #35 for the 21st Biomed Israel May 16 - 18.

    • World Orphan Drugs Conference 2023

      World Orphan Drugs Conference 2023

      Gaylord National Resort, Washington D.C, United States

      #410

      World Orphan Drugs Conference 2023

       From to 

       

       

       

       

       

      The World Orphan Drug Congress brings together leading pharmaceutical and biotech companies, government and regulatory authorities, patient advocacy groups, payers, investors and solution providers. The conference is a place to meet and brainstorm ways to advance orphan drug development and improve access to life-saving therapies.


      Join us for three days in Washington for the most comprehensive program and inclusive gathering of rare disease stakeholders.

    • ChemSpec Europe 2023

      ChemSpec Europe 2023

      Messe Basel, Switzerland

      G140

      ChemSpec Europe 2023

       From to 

       

       

       

       

       

      The 36th International Exhibition for Fine and Speciality Chemicals will take place from 24 - 25 May 2023, at Messe Basel, Switzerland.

      With a highly specialised profile, Chemspec Europe is a key event for the fine and speciality chemicals industry. The exhibition is the place to be for purchasers and agents to meet with manufacturers, suppliers and distributors of fine and speciality chemicals to source specific solutions and bespoke products.

      Chemspec Europe is a powerful gateway to global business and industry knowledge, making the event appealing to its international audience. The exhibition features the full spectrum of fine and speciality chemicals for various applications and industries. 

      Additionally, a wide range of free conferences provides excellent opportunities to network with industry colleagues and exchange competencies on the latest market trends, technical innovations, business opportunities, and regulatory issues in an evolving market.

    • CPhI China 2023

      CPhI China 2023

      SNIEC, Shanghai, China

      E1D12

      CPhI China in Shanghai

       From to 

       

       

       

       

       

      Each year CPhI unites more than 100,000 pharmaceutical professionals through exhibitions, conferences and online communities to network, identify business opportunities and expand the global market.

      Our team from Shanghai will represent CARBOGEN AMCIS and Dishman Carbogen Amcis Ltd. at the CPhI China 2023. 
      Get in contact with us and let’s meet in Shanghai!

    • BOS Basel 2023

      BOS Basel 2023

      Messe Basel, Switzerland

      33

      BOS Basel 2023

       From to 

       

       

       

       

       

      Launched in 2006 by Bio2Business Ltd, the Biotech Outsourcing Strategies Events bring together stakeholders in R&D outsourcing to share experience, build existing outsourcing partnerships and forge new buyer/supplier business relationships. The established BOS Formula is built on 4 key pillars; Exhibition showcasing international CROs and CMOs; High Quality Content (delivered through the multi-stream programme); 1-to-1 Partnering; Informal Networking (BOS Events are known for being friendly, intimate events, which create the perfect conditions for networking!).

      BOS Basel 2023 will cover Discovery Outsourcing, Small Molecule CMC Outsourcing and Biologics CMC Outsourcing.

      We are looking forward to meet you in Basel.

    • BIOSPAIN 2023

      BIOSPAIN 2023

      Fira de Barcelona

      118

      BIOSPAIN 2023

       From to 

       

       

       

       

       

      BIOSPAIN is the largest biotech event organized by a national bioindustry association in Europe and one of the largest in the world by the number of one-to-one meetings and companies participating. 

      BIOSPAIN goes back to Barcelona, the main biotech cluster in Spain and one of the most dynamic cities in the world.

      The event will take place in Pavilion 1 – Fira de Barcelona – Montjuïc. It stands in a superb location in the city center, easily accessible from the airport and well-connected to the public transport network. It is located in Montjuïc Park, an area of cultural and historical interest thanks to its museums and theatres and it also features some of the main tourist attractions in Barcelona.

      We look forward to meet you at booth #118.

    • PharmSci 360

      PharmSci 360

      Orange County Convention Center Orlando

      Booth #3330

      AAPS PharmSci 360

       From to 

       

       

       

       

       

      AAPS is the convener of the pharmaceutical science community, bringing together thousands of scientists from across the world and the drug development process. For them, PharmSci 360 combines all the energy of a large scientific conference with the intimacy of a small niche meeting because of its unique programming structure. PharmSci 360 is built on six tracks that offer both chemical and biomolecular drug programming in symposia, rapid fire presentations, and posters. Scientists attending the meeting report that they build their schedule to solve their problems, and may attend programming in only one track or all of them!

    • CPhI Worldwide 2023

      CPhI Worldwide 2023

      Fira Barcelona

      3G39

      CPHI Worldwide 2023

       From to 

       

       

       

       

       

      CPhI Worldwide will return to Barcelona from 24 - 26 October 2023. Over the last 30+ years, CPhI has provided a unique platform that unites specialist communities dedicated to improving healthcare. We offer a place where professionals can meet to exchange knowledge and do business without obstacles, helping to propel the pharmaceutical and healthcare industries forward.

    • BOS Manchester 2023

      BOS Manchester 2023

      Manchester Central

      30

      BOS Manchester 2023

       From to 

       

       

       

       

       

      Biotech Outsourcing Strategies Events bring together stakeholders in R&D outsourcing to share experience, build existing outsourcing partnerships and forge new buyer/supplier business relationships. BOS is an event where business gets gone and where you can be confident of high quality interactions with potential business partners. You will receive a warm welcome from the Bio2Business team in the vibrant and buzzing City of Manchester!

      BOS Manchester 2023 scope is primarily development stage CMC outsourcing for both Small Molecules and Biologics and also covering Novel Therapeutic Entities.

      The BOS Events story began in 2006 with the 1st event hosted in Sheffield, UK. The event format has been refined over the years and now consists of 4 key components; Programme; Partnering; Exhibition and Informal Networking.

      Get in contact with us and let's meet in Manchester.

    • BioFIT 2023

      BioFIT 2023

      Marseille, France

      BioFIT 2023

       From to 

       

       

       

       

       

      With the highest attending rate of academics, TTOs and research institutions, BioFIT is the place where academia-industry collaborations get started. BioFIT has taken on a whole new dimension becoming the meeting point in Europe for tech transfer and for sourcing early-stage innovations stemming from public research institutions, academic spin-offs and emerging biotech companies. Together with big pharma, biotech and diagnostic companies, BioFIT operates as a platform to build partnerships for all public and private actors. BioFIT is also the European marketplace for pre-seed, seed and Series A investment in Life Sciences.

      A global presence with
      9
      sites
      in Switzerland, UK, France, Netherlands & China
      More than
      40
      years
      of experience in clinical API development
      Production from gram to several
      1000
      kilogrammes
      scale manufacturing for API production
      Up to
      8000
      litres
      of capacity for API production

      For more information
      download our Company Profile
      brochure or contact us today.